Lidocain Libra-Pharm (Lidocaine)

Lidocaine is a local anesthetic used for topical management of skin surface procedures.

• Local anesthesia of the skin: provides numbing for minor surgical or diagnostic procedures on the skin.
• Pain relief for minor dermatological procedures: reduces discomfort during biopsies, laser therapy, cryotherapy or similar interventions.
• Procedural analgesia for superficial skin lesions: helps control pain during removal or treatment of small lesions.

• Lidocaine reversibly blocks voltage‑gated sodium channels on neuronal membranes, preventing the rapid influx of sodium ions required for depolarisation. This inhibition stops the initiation and propagation of nerve impulses, producing a reversible loss of sensation in the area where the drug is applied.

Lidocaine may cause a range of local and systemic reactions.

Common Side Effects

• Local irritation or burning sensation at the application site.
• Redness (erythema) of the skin.
• Itching or mild pruritus.
• Slight swelling (edema) around the treated area.
• Contact dermatitis in sensitised individuals.
• Transient numbness extending beyond the intended zone.

Serious or Rare Side Effects

• Systemic toxicity presenting as dizziness, seizures, or cardiac arrhythmias.
• Severe allergic reactions, including anaphylaxis.
• Methemoglobinemia, a rare blood disorder.
• Deep skin necrosis or ulceration.
• Persistent numbness or motor weakness.
• Respiratory depression in extreme overdose.

When using Lidocain Libra-Pharm, consider the following safety measures.

• Allergy assessment: avoid in patients with known lidocaine hypersensitivity.
• Application area: limit to intact skin; do not apply to mucous membranes or open wounds.
• Dosage control: follow prescriber instructions to prevent excessive systemic absorption.
• Concomitant anesthetics: use caution when combined with other local anesthetics to avoid additive toxicity.
• Pregnancy and lactation: only use if the potential benefit justifies the potential risk.
• Store at room temperature: keep in the original container, protect from moisture and light.

Lidocaine can interact with several drug classes; awareness helps minimise risk.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine, procainamide): may increase plasma lidocaine levels and toxicity.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): reduce lidocaine metabolism.
• Other local anesthetics: additive neuro‑cardiac toxicity.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may potentiate cardiac depressant effects.
• Loop diuretics (e.g., furosemide): can alter protein binding and increase free lidocaine.
• General anesthetics: may enhance central nervous system depression when used together.